These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7535877)

  • 1. Absence of sex-hormone receptors in Kaposi's sarcoma.
    Ziegler JL; Katongole-Mbidde E; Wabinga H; Dollbaum CM
    Lancet; 1995 Apr; 345(8954):925. PubMed ID: 7535877
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex hormones as a cofactor in the pathogenesis of epidemic Kaposi's sarcoma.
    Klauke S; Schoefer H; Althoff PH; Michels B; Helm EB
    AIDS; 1995 Nov; 9(11):1295-6. PubMed ID: 8561992
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of AIDS-associated Kaposi's sarcoma.
    Ziegler JL
    Lymphology; 1988 Mar; 21(1):15-8. PubMed ID: 2456429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lymphatic biology of Kaposi's sarcoma.
    Cheung L; Rockson SG
    Lymphat Res Biol; 2005; 3(1):25-35. PubMed ID: 15770083
    [No Abstract]   [Full Text] [Related]  

  • 5. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
    Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
    Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma.
    Skobe M; Brown LF; Tognazzi K; Ganju RK; Dezube BJ; Alitalo K; Detmar M
    J Invest Dermatol; 1999 Dec; 113(6):1047-53. PubMed ID: 10594750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma, vascular permeability, and scientific integrity.
    Markham PD
    JAMA; 1994 Sep; 272(12):920-1; author reply 922-4. PubMed ID: 7521923
    [No Abstract]   [Full Text] [Related]  

  • 8. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
    Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
    Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary capillary blood volume in patients with probable pulmonary Kaposi's sarcoma.
    Camus F; de Picciotto C; Gerbe J; Roy S; Bouchaud O; Casalino E; Perronne C
    Thorax; 1996 Feb; 51(2):204-6. PubMed ID: 8711659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
    Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
    Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma, vascular permeability, and scientific integrity.
    Albini A
    JAMA; 1994 Sep; 272(12):919-20; author reply 922-4. PubMed ID: 7521922
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions.
    Widmer I; Wernli M; Bachmann F; Gudat F; Cathomas G; Erb P
    J Virol; 2002 Mar; 76(5):2551-6. PubMed ID: 11836434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma revisited.
    Szajerka T; Jablecki J
    AIDS Rev; 2007; 9(4):230-6. PubMed ID: 18219366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus.
    Dittmer DP; Krown SE
    Curr Opin Oncol; 2007 Sep; 19(5):452-7. PubMed ID: 17762570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma of the bone marrow.
    Conran RM; Granger E; Reddy VB
    Arch Pathol Lab Med; 1986 Nov; 110(11):1083-5. PubMed ID: 3778127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction targets in Kaposi's sarcoma.
    Sullivan R; Dezube BJ; Koon HB
    Curr Opin Oncol; 2006 Sep; 18(5):456-62. PubMed ID: 16894293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells.
    Davis MA; Stürzl MA; Blasig C; Schreier A; Guo HG; Reitz M; Opalenik SR; Browning PJ
    J Natl Cancer Inst; 1997 Dec; 89(24):1868-74. PubMed ID: 9414174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma and Kaposi's sarcoma associated herpesvirus (human herpesvirus 8): where are we now?
    Chang Y
    J Natl Cancer Inst; 1997 Dec; 89(24):1829-31. PubMed ID: 9414165
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case-control study on risk factor of Kaposi's sarcoma in Xinjiang].
    Qin JM; Li F; Tan XH; Guo SX; Wang XB; Zhang WJ; Xie JX; Huang J; Pu XM; Rui DS; Yang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Sep; 26(9):673-5. PubMed ID: 16471215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.